• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/16/21 6:16:28 AM ET
    $LAIX
    Service to the Health Industry
    Miscellaneous
    Get the next $LAIX alert in real time by email
    SC 13G 1 d132355dsc13g.htm SCHEDULE 13G Schedule 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No.     )*

     

     

    LAIX Inc.

    (Name of Issuer)

    Class A ordinary shares, par value of $0.001 per share

    (Title of Class of Securities)

    50736W105**

    (CUSIP Number)

    September 14, 2018

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d–1(b)

    ☐ Rule 13d–1(c)

    ☐ Rule 13d–1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    **

    CUSIP number 50736W105 has been assigned to the American Depositary Shares (“ADSs”) of the Issuer, which are listed on the New York Stock Exchange under the symbol “LAIX.” Each ADS represents one Class A ordinary share, par value US$0.001 per share.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 50736W105

     

      (1)   

    Names of reporting persons

     

    TB Alternative Assets Ltd

      (2)  

    Check the appropriate box if a member of a group (see instructions)

    (a)  ☐        (b)  ☐

     

      (3)  

    SEC use only

     

      (4)  

    Citizenship or place of organization

     

    Cayman Islands

    Number of shares beneficially owned by

    each reporting person

    with:

       (5)    

    Sole voting power

     

    5,663,164*

       (6)   

    Shared voting power

     

    0

       (7)   

    Sole dispositive power

     

    5,663,164

       (8)   

    Shared dispositive power

     

    0

      (9)  

    Aggregate amount beneficially owned by each reporting person

     

    5,663,164

    (10)  

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

    Percent of class represented by amount in Row (9)

     

    11.46%**

    (12)  

    Type of reporting person (see instructions)

     

    IA, Investment Adviser

     

    *

    Number of shares beneficially owned (includes 5,663,164 ADS) as of 31 Dec 2020.

     

    *

    Calculation is based on 49,412,233 outstanding ordinary shares for all classes as of 31 Dec 2020.


    Highlight and copy the table if more than one is required.

     

      SCHEDULE 13G    Page 3  of 5

     

    Item 1(a)

    Name of issuer: LAIX Inc.

     

    Item 1(b)

    Address of issuer’s principal executive offices: 3/F, Building B, No. 1687 Changyang Road, Yangpu District, Shanghai, 200090, People’s Republic of China

    2(a) Name of person filing: TB Alternative Assets Ltd

    This statement is filed by TB Alternative Assets Ltd, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, with respect to the portion of American Depository Shares held by Trustbridge Partners V LP, a Cayman business company that is controlled by TB Alternative Assets Ltd. TB Alternative Assets Ltd acts as the investment adviser of Trustbridge Partners V LP

    2(b) Address or principal business office or, if none, residence: c/o Maples Corporate Services Limited, Ugland House, Grand Cayman, Cayman Islands, KY1-1104

    2(c) Citizenship: Cayman Islands

    2(d) Title of class of securities: Class A ordinary shares, par value of $0.001 per share

    2(e) CUSIP No.: 50736W105

     

    Item 3.

    If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8);
    (e)    ☒    An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
    (j)    ☐    A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution:                                                  

     

    Item 4.

    Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)

    Amount beneficially owned: 5,663,164

     

    (b)

    Percent of class: 11.46%


      SCHEDULE 13G    Page  4  of 5

     

    (c)

    Number of shares as to which the person has:

     

      (i)

    Sole power to vote or to direct the vote: 5,663,164

     

      (ii)

    Shared power to vote or to direct the vote: 0

     

      (iii)

    Sole power to dispose or to direct the disposition of: 5,663,164

     

      (iv)

    Shared power to dispose or to direct the disposition of: 0

     

    Item 5.

    Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [    ].

    Dissolution of a group requires a response to this item.

     

    Item 6.

    Ownership of More than 5 Percent on Behalf of Another Person.

    Not Applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not Applicable

     

    Item 9.

    Notice of Dissolution of Group.

    Not Applicable

     

    Item 10.

    Certifications

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under §240.14a-11.


      SCHEDULE 13G    Page  5  of 5

    Signatures

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: 02/11/2021                         Signature:  

    /s/ Shujun Li

        Name:  

    Shujun Li

        Title:  

    Director

    Get the next $LAIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAIX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • LAIX Inc. Announces Plan to Implement ADS Ratio Change

      SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio"), par value US$0.001 per share, from the current ADS Ratio of one (1) ADS to one (1) Class A ordinary share to a new ADS Ratio of one (1) ADS to fourteen (14) Class A ordinary shares. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The Company antic

      2/21/22 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • LAIX Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

      SHANGHAI, Sept. 28, 2021 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated September 17, 2021 and further e-mail communication on the same date, notifying the Company that (i) it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs"), and (ii) the applicable cure period for the Company to regain compliance expires on March 17, 2022. Pursuant to applicable NYSE continued listing stan

      9/28/21 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Leadership Updates

    Live Leadership Updates

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services

    $LAIX
    SEC Filings

    See more
    • SEC Form SC 13E3 filed by LAIX Inc.

      SC 13E3 - LAIX Inc. (0001742056) (Subject)

      7/11/22 8:52:23 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/27/22 4:02:01 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/17/22 9:10:37 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      7/8/22 1:51:02 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D filed by LAIX Inc.

      SC 13D - LAIX Inc. (0001742056) (Subject)

      6/23/22 6:03:17 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      6/21/22 6:17:08 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous